LRLeonid Mikhailovich Rapoport

Leonid Mikhailovich Rapoport

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Leonid Mikhailovich Rapoport has a total of 208 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Partial nephrectomy for locally advanced renal cell carcinoma in a solitary functioning kidney renal cell carcinoma

    by Ya. N. Chernov, E. N. Shpot, D. V. Chinenov, L. M. Rapoport, D. O. Korolev, V. P. Glybochko, Kh. A. Khizriev, M. D. Trishkin, I. N. Kurepta, E. A. Smirnova, et al.

    BACKGROUND: Locally advanced stage cT3a renal cell carcinoma is characterized by invasion of paranephric cellular tissue, renal sinus or main venous structures and is diagnosed in 20–30 % of cases. While radical nephrectomy remains the “gold standard”, data accumulated in recent years show comparable oncological safety of kidney resection for stage cT3a disease. Patients with solitary kidney remain the most controversial group. AIM: To evaluate immediate, perioperative and early functional results of resection of single-functioning kidney in patients with locally advanced stage cT3a cancer of renal parenchyma. METHODS: The retrospective-prospective study included patients with stage cT3a cancer of renal parenchyma who underwent surgery at the Institute of Human Urology and Reproductive Health of the Sechenov First Moscow State Medical University between January 2014 and October 2025. All patients underwent kidney resection. In total, 20 (2.8 %) of 703 patients had single-functioning kidney. Clinical, anatomical, perioperative, early functional characteristics, as well as frequency of achieving renal trifecta and pentafecta, in these patients and 356 patients who underwent organ-saving treatment and have two kidneys were compared. RESULTS: Patients with solitary kidney had higher creatinine level (104.50 µmol/L versus 90.45 µmol/L; p = 0.0015), lower glomerular filtration rate (56.37 mL/min/1.73 m² versus 71.74 mL/min/1.73 m²; p p = 0.0171). Operative time was shorter in patients with solitary kidney compared to patients with two kidneys (95 min versus 120 min; p = 0.0220). No differences were found in ischemia time, blood loss volume and duration of hospitalization. Negative surgical margin (R0) rate in patients with solitary kidney was lower (55.0 % versus 90.0 %; p = 0.0055). Frequencies of achieving trifecta (63.6 % versus 77.7 %; p = 0.2790) and pentafecta (45.5 % versus 35.7 %; p = 0.5357) did not show significant differences. CONCLUSION: Resection of single-functioning kidney in locally advanced stage cT3a cancer of renal parenchyma is technically feasible and is accompanied by perioperative profile comparable to profile of patients with two kidneys except for higher risk of positive surgical margin. Imperative character of the intervention requires accurate planning of resection volume and personalization of surgical tactics.

  • Open Access

    Overstaging and understaging in cT3a renal cell carcinoma: development and application of an online pT3a prediction calculator

    by Ya. N. Chernov, E. V. Shpot, D. V. Chinenov, L. M. Rapoport, D. O. Korolev, V. P. Glybochko, Kh. A. Khizriev, M. D. Trishkin, I. N. Kurepta, E. A. Smirnova, et al.

    BACKGROUND: Clinical stage cT3a renal cell carcinoma commonly prompts radical nephrectomy, but overdiagnosis of local invasion occurs in 5–10%. Unnecessary nephrectomy causes loss of functional parenchyma and chronic kidney disease risk. Available tools assess anatomical complexity but fail to definitively confirm pT3a, leaving interpretation to the clinician. AIM: To assess the rate and pattern of overstaging of clinical stage cT3a renal cell carcinoma and to demonstrate the clinical application of an online calculator, developed from these data, for predicting the true pathological stage pT3a. METHODS: The study included 703 patients with cT3a stage renal cell carcinoma who underwent surgical treatment between 2014 and 2025. Among 629 patients with histologically verified renal cell carcinoma, groups of pathologically confirmed pT3a ( n = 243) and overstaging cT3a → pT1–2 ( n = 386) were identified; in an extended cohort ( n = 689), 60 additional cases of understaging (cT1–2 → pT3a) were identified. Groups were compared by clinico-anatomical characteristics. Based on a previously developed combined clinico-radiomic model (area under the curve (AUC) = 0.89), a publicly available online calculator for preoperative prediction of pT3a probability was created. RESULTS: The overstaging rate of clinical stage cT3a was 61.4 % (386/629): only 38.6 % of patients had morphologically confirmed pT3a. The overstaging group differed significantly from the confirmed pT3a group in R.E.N.A.L. score (9 vs 10 points; p 3–4 (21.5 % vs 35.9 %; p CONCLUSION: The high rate of overstaging of clinical stage cT3a justifies the need for objective preoperative prediction tools. The developed online calculator provides a practical, real-time application of the clinico-radiomic model directly during preoperative patient counseling.

  • Open Access

    Assessment of awareness and help-seeking behavior for surgical treatment among men with stress urinary incontinence after prostate surgery

    by M. A. Asadulaev, M. E. Enikeev, D. O. Korolev, A. F. Abdusalamov, I. A. Akbulatov, D. M. Murugov, V. K. Rodionova, A. M. Ponomareva, L. M. Rapoport, М. М. Асадулаев, et al.

    BACKGROUND : Stress urinary incontinence (SUI) is a significant complication of prostate surgery and severely impacts patients’ quality of life. Despite the availability of effective surgical correction methods, some patients do not seek specialized care, which may be related to insufficient awareness of available treatment options. AIM : To assess the level of awareness and the frequency of seeking specialized care among men with SUI after prostate surgery. METHODS : A single-center retrospective study of data from 2023–2026 was conducted on 2 groups of patients. The group 1 consisted of 32 men who sought consultation regarding SUI. The group 2 included 80 patients who were surveyed by phone to assess their awareness of surgical treatment for SUI. RESULTS : Among the patients seeking consultation, those with severe SUI predominated. The latest consultations were observed in patients with mild SUI. Less than half of the respondents were aware of the possibility of surgical treatment. CONCLUSION: Insufficient awareness and delayed help-seeking, especially in patients with mild incontinence, indicate the need for earlier patient education regarding available surgical options for this condition.

  • Surgical strategy for rectourethral fistulas after prostate cancer surgery

    by M. M. Asadulaev, M. E. Enikeev, D. O. Korolev, P. V. Tsarkov, A. M. Shlomina, S. K. Efetov, I. V. Fokin, L. M. Rapoport

    Introduction: rectourethral fistula (RUF) is a rare but severe complication after radical prostatectomy (RP), which significantly reduces the quality of life of patients. There are several treatment methods, including transposition of the gracilis muscle ( m. gracilis ) of the thigh, which shows positive results due to excellent vascularization and ease of mobilization. Aim: to evaluate the effectiveness of staged surgical treatment of RUF in patients after RP using a transperineal approach and a m. gracilis flap. Materials and methods: the study included 5 patients with RUF: 3 patients after RP; 2 patients after cryoablation for prostate cancer (PCa) treatment. All patients underwent staged surgical treatment: stage 1 — supravesical urine diversion with installation of nephrostomy tubes; stage 2 — transperineal excision of the fistula and transposition of the m. gracilis flap. The results were assessed on post-operative day 14–16: proctography, pericatheter or micturition cystourethrography were performed. The next day, the urethral catheter was removed, followed by removal of the cystostomy drainage and closure of the colostomy. Results: the average age of patients was 62 years (from 58 to 67 years). Successful healing of the rectourethral fistula was observed in all patients which was confirmed by control proctography and micturition cystourethrography. In one patient a urethroperineal fistula developed after surgery, that required additional surgery, which was combined with a one-stage closure of the colostomy. Conclusion: transperineal approach using the gracilis flap demonstrates high efficiency rate in the treatment of RUF in patients after surgical treatment of prostate cancer.

  • Treatment features of localised bladder amyloidosis: case report and literature review

    by I. V. Fokin, C. A. Azilgareeva, M. A. Mustafin, D. O. Korolev, Yu. V. Lerner, V. V. Rameev, L. M. Rapoport, M. E. Enikeev

    Local amyloidosis of the bladder is a rare disease characterized by the colonization of the bladder wall by an abnormal clone of plasma cells that produce amyloidogenic immunoglobulin light chains. According to modern classification, this condition is classified as AL amyloidosis (A for amyloidosis, L for light chains of immunoglobulins). In cases of local amyloidosis, the amyloidogenic light chains of immunoglobulins are not present in the bloodstream, as the clone functions locally in the tissue and the synthesized immunoglobulins are retained by the interstitial tissue. As a result, plasma cells encased in amyloid are not accessible to chemotherapy. Due to this limitation, chemotherapy is not a viable treatment option for local amyloidosis. Radiation therapy is also not recommended as it could cause significant damage to the regenerative capacity of the bladder wall, leading to a reduction in mechanical strength and functionality. Therefore, the primary treatment method for local amyloidosis of the bladder is transurethral resection. In cases of recurrent forms, patients may be offered open or laparoscopic resection of the bladder wall or cystectomy. This case study presents a clinical observation of a patient with local amyloidosis of the bladder, highlighting the challenges in diagnosis and discussing potential approaches to surgical treatment.

  • Open Access

    Successful endovascular treatment of recurrent venocorporeal erectile dysfunction using a liquid non-adhesive embolizing agent "KAP". Case report

    by D. G. Ioseliani, A. G. Koledinskiy, S. P. Semitko, L. M. Rapoport, D. A. Asadov, N. V. Petrovskii, K. V. Gyulmisaryan, V. V. Fomenko, S. A. Kibets, I. E. Chernysheva, et al.

    According to the Russian Society of Urologists, almost half of the male population of the country aged 27 to 77 suffers from erectile dysfunction (ED). ED should be considered not only as a serious medical nosology, but also as an important socio-psychological problem of national importance due to its demographic significance. There are many methods of treating ED, including drug therapy and penile prosthetics, as well as certain psychotherapeutic measures. The world's experience in combating this disease allows us to assert that an important condition for determining the correct approach to treating ED is an accurate diagnosis of the causes of ED. Among the many causes of ED, vascular causes are quite common. Given the rapid development of endovascular and low-traumatic approaches to vascular pathology, the method of improving the inflow and obstructing the outflow in vasculogenic ED is becoming increasingly obvious and effective. The presented article discusses a clinical case of successful endovascular complex treatment of recurrent venocorporeal ED in a young patient.

  • Open Access

    Development of a deep learning-based system for aiding in the determination of Prostate Imaging Reporting and Data System (PI-RADS) scores: an international multicenter study

    by Mingze He, M. E. Enikeev, R. T. Rzaev, I. M. Chernenkiy, M. V. Feldsherov, He Li, Kebang Hu, E. V. Shpot, L. M. Rapoport, P. V. Glybochko

    Background. Prostate multiparametric magnetic resonance imaging is widely recommended prior to biopsy in clinical practice, with the Prostate Imaging Reporting and Data System (PI-RADS) as the standard tool for guiding diagnosis and treatment decisions. However, analyzing multiparametric magnetic resonance imaging data demands substantial expertise, and the process is often time-intensive and cognitively challenging, leading to variability between and within readers.Aim. To create a deep learning-based computer-aided diagnosis (DL-CAD) system to minimize manual influence on PI-RADS score determination.Materials and methods. Between January 2020 and May 2024, 108 patients with histopathologically confirmed prostate cancer with PI-RADS scores 4–5 were retrospectively selected for model development and training. Additionally, 28 benign cases were included for model validation. Different prostate zones were labeled following PI-RADS v2.1 guidelines to facilitate model selection. Manual segmentation of prostate regions and lesions was performed on T2-weighted (T2W) sequences, and a 3D U-Net architecture was implemented for the DL model using the MONAI framework. Diagnostic performance was assessed using Python-based statistical analysis.Results. The DL-CAD system achieved average accuracy of 78 %, sensitivity of 60 %, and specificity of 84 % for lesion detection. The Dice similarity coefficient for prostate segmentation was 0.71, and the AUROC was 81.16 %.Conclusion. The DL-CAD system demonstrates promise for patients with clinically significant prostate cancer by improving diagnostic accuracy. While it exhibits high specificity, further improvements of sensitivity and segmentation accuracy are necessary. These improvements could be achieved through the use of larger datasets and advanced deep learning techniques, such as transfer learning or ensemble learning, which could enhance sensitivity without compromising specificity. Further multicenter validation is required to accelerate the integration of this system into clinical practice.

  • Analysis of the results of surgical treatment of renal cancer patients with extended venous tumor thrombosis

    by Komarov, L.M. Rapoport, M. Shao, N.S. Bashmakov, Yu.V. Belov, B.M. Tlisov, A.V. Zavaruev

    Medical centers in China and Russia have different surgical management for renal cancer with tumor thrombosis of the venous and right atrium. The main differences are the surgical accesses, the use of cardiopulmonary bypass (CPB) and the temperature regime in cases of CPB. Objective. To evaluate the results of radical nephrectomy and tumor thrombectomy of the inferior vena cava in different medical centers of China and Russia. Material and methods. We retrospectively analyzed and compared the outcomes of 14 patients with renal cancer and tumor venous thrombosis who underwent surgical treatment from 2015 to 2018 in two medical institutions in China (CNKI database) and 35 patients operated on from 2010 to 2022 in medical centers in Russia. Results. The average duration of surgery in Russian hospitals was 333.2 min, blood loss was 2097.9 ml, and the incidence of postoperative complications was 37.1%; the average duration of surgery in Chinese hospitals was 415.1 min, blood loss was 3635.7 ml, and the incidence of postoperative complications was 57.1%. Conclusion. The results of radical nephrectomy with tumor thrombosis in Chinese and Russian medical centers are comparable. The use of normothermic artificial circulation allows to reduce blood loss and shorten the duration of surgery.

  • Open Access

    Clinical significance of clinicopathological features in predicting surgical treatment and risk of complications in renal cancer with venous tumor thrombosis

    by R. N. Komarov, L. M. Rapoport, M. Shao, D. O. Korolev, M. He, R. I. Slusarenko, I. B. Lutsenko, И. В. Луценко

    Aim. To study and analyze the surgical results and prognostic factors accompanying radical nephrectomy combined with venous thrombectomy in renal cancer patients with venous tumor thrombosis. Materials and  methods . Retrospective analysis of clinical data of patients with renal cancer and venous tumor thrombosis who underwent surgical treatment at the Clinic of Cardiovascular Surgery and the Clinic of Urology of the I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University) from May 2010 to February 2023. Kaplan–Meier analysis was used to obtain overall survival curves and log-rank tests were used for statistical comparisons; Cox regression models were used for multivariate analysis of survival and complications to find independent risk factors affecting prognosis. Results. A total of 42 patients were included, 15 patients with grade 0–II tumor thrombosis and 27 patients with grade III–IV thrombosis. There were 3 perioperative deaths. The 5-year postoperative survival rate of patients was 68 %. Cox regression analysis: stage Т: HR = 0.515, 95 % confidential interval (CI) 0.111–2.393, p = 0.397; stage N: HR = 1.430, 95 % CI 0.380–5.457, p = 0.592; stage М: HR = 3.312, 95 % CI 0.811–4.561, p = 0,138; time of operation: HR = 1.001, 95 % CI 0.997–1.004, p = 0.771. Conclusion. Kidney cancer patients with venous tumor thrombosis have better surgical treatment results, which may significantly improve their prognosis compared with non-operated patients. Stage N and stage M were important factors directly affecting patients’ survival (HR >1), but the level of tumor thrombosis could not be a factor affecting patients’ survival (HR = 1), but p >0.05, so it was not statistically significant. The level of tumor thrombosis and the duration of surgery affect the intraoperative blood loss, and the greater the intraoperative blood loss, the higher the stage of early postoperative complications and the worse the patient’s prognosis.

  • Open Access

    Surgical access in treatment of kidney cancer complicated by tumor thrombosis of the inferior vena cava and right atrium

    by R. N. Komarov, L. M. Rapoport, M. Shao, M. I. Tkachev, B. M. Tlisov, A. V. Zavaruev, A. O. Simonyan

    This article discusses the choice of surgical access in renal cancer complicated by tumor thrombus with invasion into the inferior vena cava and the right atrium. This clinical scenario poses a major challenge to the surgeons, as tumor thrombus can obstruct access to the surgical area and increase the risk of complications. This article discusses various surgical access techniques that can be used in treatment of kidney cancer complicated by tumor thrombus of the inferior vena cava and right atrium, including open surgery, robotic surgery, and minimally invasive techniques. An analysis of factors to consider in selection of the optimal surgical access was perfomed.